{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:04Z","timestamp":1759336504550,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nrl.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T11:08:48Z","timestamp":1532603328000},"page":"423-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diston\u00eda miocl\u00f3nica y ataxia cerebelosa en la autoinmunidad antiglut\u00e1mico-descarboxilasa"],"prefix":"10.1016","volume":"35","author":[{"given":"\u00cd.","family":"Isern de Val","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gazulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2018.05.004_bib0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2008.04.019","article-title":"Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies","volume":"271","author":"Ishida","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2018.05.004_bib0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.2006.091116","article-title":"Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia","volume":"78","author":"Ishida","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2018.05.004_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nrl.2018.05.004_bib0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.22425","article-title":"Myoclonus-dystonia: An update","volume":"24","author":"Kinugawa","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2018.05.004_bib0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jnnp.2008.162099","article-title":"Myoclonus-dystonia: Clinical and genetic evaluation of a large cohort","volume":"80","author":"Ritz","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2018.05.004_bib0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/0972-2327.168625","article-title":"Sporadic and familial myoclonic dystonia: Report of three cases and review of the literature","volume":"19","author":"Bhattacharyya","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.nrl.2018.05.004_bib0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.58.3.368","article-title":"Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults","volume":"58","author":"Kuzniecky","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.05.004_bib0115","series-title":"Antiepileptic Drugs","first-page":"1057","article-title":"Potential antiepileptic drugs. Tiagabine","author":"Ostergaard","year":"1995"},{"key":"10.1016\/j.nrl.2018.05.004_bib0120","series-title":"Farmacolog\u00eda humana","first-page":"409","article-title":"Neurotransmisi\u00f3n en el sistema nervioso central","author":"Fl\u00f3rez","year":"1997"},{"key":"10.1016\/j.nrl.2018.05.004_bib0125","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.49.4.1026","article-title":"Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset diabetes mellitus and polyendocrine autoimmunity","volume":"49","author":"Saiz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.05.004_bib0130","first-page":"629","article-title":"Neurotransmitters in the cerebellum","volume":"11","author":"Ottersen","year":"1993","journal-title":"Rev Neurol (Par\u00eds)"},{"key":"10.1016\/j.nrl.2018.05.004_bib0135","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.2174\/1381612821666150914120923","article-title":"GABAergic pharmacotherapy in the treatment of motor disorders of the central nervous system","volume":"21","author":"Gazulla","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nrl.2018.05.004_bib0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-510X(85)90059-0","article-title":"Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy","volume":"71","author":"Kanazawa","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2018.05.004_bib0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(82)91059-5","article-title":"Cerebrospinal fluid gamma-aminobutiric acid variations in cerebellar ataxia","volume":"2","author":"Ogawa","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2018.05.004_bib0150","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1474-4422(03)00534-9","article-title":"Excellent response to steroid treatment in anti-GAD cerebellar ataxia","volume":"2","author":"Lauria","year":"2003","journal-title":"Lancet Neurol"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485318301774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485318301774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:11:02Z","timestamp":1759324262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485318301774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0213485318301774"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2018.05.004","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diston\u00eda miocl\u00f3nica y ataxia cerebelosa en la autoinmunidad antiglut\u00e1mico-descarboxilasa","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}